Related Experiment Videos
Recombination between the postulated CCD/MHE/MHS locus and RYR1 gene markers
T H Fagerlund1, G Islander, E Ranklev-Twetman
1Institute of Medical Genetics, University of Oslo, Norway.
Abstract:
Malignant hyperthermia (MH) susceptibility is considered a subclinical myopathy or a pharmacogenetic trait, and is believed to be closely associated with central core disease (CCD). Data support the notion that MH susceptibility is heterogeneous, with the ryanodine receptor I (RYR1) locus on chromosome 19 being one locus harboring a gene that can cause MH susceptibility. The gene for CCD is believed to reside in the locus on chromosome 19. In the family presented here, a girl has CCD, and several close relatives are MH susceptible (MHS). DNA studies conducted on available family members uncovered recombination between the MH susceptibility locus and RYR1 markers. Consequently, if one postulates that the CCD gene in this family resides in the same locus as the MH susceptibility gene, an additional CCD locus different from the RYR1 locus must also be postulated.
Insights
Malignant hyperthermia susceptibility (MHS) and central core disease (CCD) are linked, but this study found genetic evidence suggesting a new CCD gene locus distinct from the RYR1 gene. This finding impacts understanding of these related neuromuscular disorders.
Area of Science:
- Genetics
- Neuromuscular Disorders
- Pharmacogenetics
Background:
- Malignant hyperthermia (MH) susceptibility is a pharmacogenetic trait often associated with central core disease (CCD).
- The ryanodine receptor I (RYR1) gene on chromosome 19 is a known locus for MH susceptibility and is thought to harbor the CCD gene.
- MH susceptibility is recognized as genetically heterogeneous.
Observation:
- A family with a child diagnosed with CCD and several MH susceptible (MHS) relatives was studied.
- DNA analysis revealed recombination between the MH susceptibility locus and RYR1 markers within this family.
- This genetic recombination suggests a more complex inheritance pattern than previously understood.
Findings:
- The observed recombination indicates that the MH susceptibility locus and the RYR1 gene are not perfectly linked in all cases.
- If the CCD gene in this family is linked to the MH susceptibility locus, it implies the existence of a separate CCD gene locus.
- This separate locus for CCD is distinct from the established RYR1 locus.
Implications:
- The findings suggest that central core disease may have genetic heterogeneity, with at least two distinct loci involved.
- This challenges the long-held assumption that MH susceptibility and CCD are solely linked to the RYR1 gene.
- Further research is needed to identify the novel CCD locus and understand its relationship with MH susceptibility and RYR1 mutations.